TOMS Capital pushes for Kenvue sale, Bloomberg News reports

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

March 23 (Reuters) - Investment firm TOMS Capital Investment Management has amassed a stake in the Band-Aid maker Kenvue ( KVUE ) and is pushing the company to consider a full sale or separation of some assets, Bloomberg News reported on Sunday, citing people with knowledge of the matter.

It was not immediately clear the extent of the hedge fund's total stakeholding in Kenvue ( KVUE ).

Kenvue ( KVUE ), previously a part of Johnson & Johnson ( JNJ ), settled a four-month battle with activist investor Starboard Value earlier this month by appointing three new directors to its board as part of an agreement.

Starboard Value built a stake in Kenvue ( KVUE ) in October, sparking criticism over the lackluster performance in the skin health and beauty segment, which houses brands such as Neutrogena and Aveeno.

TOMS Capital declined to comment and Kenvue ( KVUE ) did not immediately respond to a Reuters request for comment, while a spokesperson for Kenvue ( KVUE ) told Bloomberg News, "Kenvue's ( KVUE ) board and management team are committed to acting in the best interests of the company and all shareholders and we remain focused on accelerating sustainable, profitable growth and enhancing shareholder value." (Reporting by Kritika Singh in Bengaluru; editing by Diane Craft)

(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.